Nothing Special   »   [go: up one dir, main page]

ATE539816T1 - Verfahren zum diagnostischen testen - Google Patents

Verfahren zum diagnostischen testen

Info

Publication number
ATE539816T1
ATE539816T1 AT02766923T AT02766923T ATE539816T1 AT E539816 T1 ATE539816 T1 AT E539816T1 AT 02766923 T AT02766923 T AT 02766923T AT 02766923 T AT02766923 T AT 02766923T AT E539816 T1 ATE539816 T1 AT E539816T1
Authority
AT
Austria
Prior art keywords
membrane
capture
analyte
sample
incubation chamber
Prior art date
Application number
AT02766923T
Other languages
English (en)
Inventor
Andrew Sloane
Andrew Gooley
Robert Cole
Original Assignee
Proteome Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR7144A external-priority patent/AUPR714401A0/en
Priority claimed from AU2002950212A external-priority patent/AU2002950212A0/en
Application filed by Proteome Systems Ltd filed Critical Proteome Systems Ltd
Priority claimed from PCT/AU2002/001119 external-priority patent/WO2003016902A1/en
Application granted granted Critical
Publication of ATE539816T1 publication Critical patent/ATE539816T1/de

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0642Filling fluids into wells by specific techniques
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0825Test strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/16Surface properties and coatings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0633Valves, specific forms thereof with moving parts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81Tube, bottle, or dipstick

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Clinical Laboratory Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
AT02766923T 2001-08-20 2002-08-20 Verfahren zum diagnostischen testen ATE539816T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPR7144A AUPR714401A0 (en) 2001-08-20 2001-08-20 Method and apparatus for screening for immunoreactivity against disease
AUPR945101 2001-12-12
AU2002950212A AU2002950212A0 (en) 2002-07-11 2002-07-11 Diagnostic testing process
PCT/AU2002/001119 WO2003016902A1 (en) 2001-08-20 2002-08-20 Diagnostic testing process and apparatus

Publications (1)

Publication Number Publication Date
ATE539816T1 true ATE539816T1 (de) 2012-01-15

Family

ID=32180066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02766923T ATE539816T1 (de) 2001-08-20 2002-08-20 Verfahren zum diagnostischen testen

Country Status (6)

Country Link
US (2) US7205159B2 (de)
EP (1) EP1419387B1 (de)
JP (1) JP4264348B2 (de)
AT (1) ATE539816T1 (de)
AU (1) AU2002331408B2 (de)
CA (1) CA2457930C (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457930C (en) * 2001-08-20 2012-06-19 Proteome Systems Intellectual Property Pty Ltd. Diagnostic testing process and apparatus
DE60219207T2 (de) * 2001-12-12 2008-01-24 Proteome Systems Intellectual Property Pty. Ltd., North Ryde Diagnostisches testverfahren
ES2812629T3 (es) * 2004-11-24 2021-03-17 Techlab Inc Dispositivo para la detección de analitos
WO2006080021A2 (en) 2005-01-31 2006-08-03 Realbio Technologies Ltd. Multistep reaction lateral flow capillary device
ES2640295T3 (es) 2005-04-04 2017-11-02 Biogen Ma Inc. Métodos para evaluar una respuesta inmune a un agente terapéutico
US7824927B2 (en) * 2005-04-05 2010-11-02 George Mason Intellectual Properties, Inc. Analyte detection using an active assay
GB0509422D0 (en) 2005-05-09 2005-06-15 Mabtech Ab Membranes
US7279136B2 (en) 2005-12-13 2007-10-09 Takeuchi James M Metering technique for lateral flow assay devices
US20070224701A1 (en) * 2006-02-16 2007-09-27 Becton, Dickinson And Company Combination vertical and lateral flow immunoassay device
WO2007100770A2 (en) 2006-02-28 2007-09-07 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
US20070231319A1 (en) 2006-03-03 2007-10-04 Yednock Theodore A Methods of treating inflammatory and autoimmune diseases with natalizumab
AU2007235649A1 (en) * 2006-04-10 2007-10-18 3M Innovative Properties Company Nucleic acid detection using lateral flow methods
US20110184747A1 (en) * 2006-08-09 2011-07-28 Carmen Bozic Method for distribution of a drug
US7749775B2 (en) * 2006-10-03 2010-07-06 Jonathan Scott Maher Immunoassay test device and method of use
FR2918460B1 (fr) * 2007-07-02 2013-10-04 Najim Chaibi Nouveau dispositif permettant l'obtention des resultats des systemes abo,rhesus et autres pherotypes et systemes rares, rai.
EP2128617A1 (de) * 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Vorrichtung und Verfahren zur Feststellung von Analyten in der Spucke
CN102076415B (zh) 2008-06-29 2015-06-24 瑞尔比奥技术有限公司 尤其可用作生物测定过程中的捕捉装置的液体转移装置
CA2740902C (en) 2008-10-17 2016-10-04 Medmira Inc. Downward or vertical flow diagnostic device and assay
JP2012513586A (ja) * 2008-12-22 2012-06-14 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 磁気ラベルを使用するトロポニンiに関するアッセイ
KR101024382B1 (ko) 2009-02-19 2011-03-23 주식회사 올메디쿠스 생체물질 분석용 테스트 스트립
US8012770B2 (en) 2009-07-31 2011-09-06 Invisible Sentinel, Inc. Device for detection of antigens and uses thereof
CN102612555A (zh) 2009-10-09 2012-07-25 因威瑟堡善迪诺有限公司 用于检测抗原的装置及其应用
JP2013507618A (ja) 2009-10-11 2013-03-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗vla‐4関連アッセイ
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
EP2524060B1 (de) 2010-01-11 2017-11-29 Biogen MA Inc. Assay für jc-viren-antikörper
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
CA2805653A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
EP2668501B1 (de) 2011-01-27 2019-06-12 Invisible Sentinel, Inc. Analytnachweisvorrichtungen, multiplex- und tischplattenvorrichtungen für den nachweis von analyten und verwendungen davon
DK2715352T3 (da) 2011-05-31 2019-05-20 Biogen Ma Inc Fremgangsmåde til vurdering af risiko for pml
EP2691530B1 (de) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv-glycoproteine und rekombinante vektoren
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
BR122020013379B1 (pt) 2011-09-30 2023-01-03 Teva Pharmaceuticals Australia Pty Ltd Anticorpos contra tl1a e seus usos
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
US20130164193A1 (en) 2011-12-22 2013-06-27 Life Technologies Corporation Sequential lateral flow capillary device for analyte determination
US9005991B2 (en) 2012-01-05 2015-04-14 American Bio Medica Corporation Device and method for testing biological samples
WO2013132338A2 (en) 2012-03-06 2013-09-12 Calpro As Competitive immunoassay for calprotectin
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
EP3578980B1 (de) 2012-03-09 2021-09-15 Invisible Sentinel, Inc. Verfahren und zusammensetzungen zur erkennung von mehreren analyten mit einem einzigen signal
FR2991689B1 (fr) * 2012-06-11 2018-04-20 Diagast Dispositif de diagnostic immuno-hematologique et utilisations
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
DK2951208T3 (da) 2013-02-01 2020-01-13 Kira Biotech Pty Ltd Anti-cd83 antistoffer og anvendelse deraf
WO2014121325A1 (en) 2013-02-07 2014-08-14 Csl Limited Il-11r binding proteins and uses thereof
US9588114B2 (en) 2013-04-23 2017-03-07 Montecito Bio Sciences Ltd Flow through testing system with pressure indicator
US10119976B2 (en) 2013-05-28 2018-11-06 Biogen Ma Inc. Method of assessing risk of PML
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US11033896B2 (en) * 2014-08-08 2021-06-15 Ortho-Clinical Diagnostics, Inc. Lateral-flow assay device with filtration flow control
US10870704B2 (en) 2014-10-23 2020-12-22 Kira Biotech Pty Limited CD83 binding proteins and uses thereof
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
KR102582602B1 (ko) 2015-05-05 2023-09-25 메조블라스트 인터내셔널 에스에이알엘 효능 검정
WO2016205585A1 (en) 2015-06-17 2016-12-22 The Johns Hopkins University Compositions and methods for detection of malaria parasite biomarkers
EP4137562A1 (de) 2017-05-04 2023-02-22 Mesoblast International Sàrl Mesenchymale linienvorläufer oder stammzellen mit erhöhter immunsuppression
GB201811597D0 (en) 2018-07-16 2018-08-29 Hemogad Tech Ltd Analyser
US20220143097A1 (en) 2019-01-02 2022-05-12 Mesoblast International Sárl Method for treating lower back pain
WO2022034467A1 (en) 2020-08-10 2022-02-17 Mesoblast International Sarl A composition comprising mesenchymal precursor or stem cells and their use
WO2024009226A1 (en) 2022-07-05 2024-01-11 Mesoblast International Sarl Cryopreserved intermediate and potency assay for same

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US570049A (en) * 1896-10-27 peelich
US124077A (en) * 1872-02-27 Improvement in processes for desulphurizing ores
US631288A (en) * 1899-04-17 1899-08-22 Julius Fey Bag-holder.
US4246339A (en) * 1978-11-01 1981-01-20 Millipore Corporation Test device
TW203120B (de) * 1985-10-04 1993-04-01 Abbott Lab
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
US5763262A (en) * 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
US5137691A (en) * 1987-01-27 1992-08-11 V-Tech, Inc. Antibody testing system with removable air gap
US4912034A (en) * 1987-09-21 1990-03-27 Biogenex Laboratories Immunoassay test device and method
US5137804A (en) 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US4877586A (en) * 1988-07-27 1989-10-31 Eastman Kodak Company Sliding test device for assays
DE69016267T2 (de) * 1989-06-05 1995-05-24 Janssen Pharmaceutica Nv Festphasen-Test zur Verwendung mit einem physikalischen Entwickler.
US5185127A (en) * 1989-09-21 1993-02-09 Becton, Dickinson And Company Test device including flow control means
AU637480B2 (en) 1990-03-12 1993-05-27 Biosite Diagnostics Incorporated Bioassay device with non-absorbent textured capillary surface
DE69311944T2 (de) * 1992-04-01 1997-11-20 Nihon Millipore Kogyo K K Verfahren zur Bestimmung der Anzahl lebender Mikroorganismen
GB9322650D0 (en) 1993-11-03 1993-12-22 Cogent Diagnostics Ltd Analytical device
US5658801A (en) 1994-05-03 1997-08-19 Spectral Diagnostics Inc. Medical test kit
AUPM765894A0 (en) * 1994-08-26 1994-09-15 University Of Sydney, The Particle detection and identification
US20010051350A1 (en) 1995-05-02 2001-12-13 Albert Nazareth Diagnostic detection device and method
EP0972073A1 (de) * 1996-09-25 2000-01-19 Universal Healthwatch, Inc. Diagnostische testanordnung mit verbesserter flüssigkeitsbeweglichkeit und widerstandsfähigkeit gegenüber chemischer interaktionen
GB9700759D0 (en) 1997-01-15 1997-03-05 Carbury Herne Limited Assay device
US6057165A (en) 1997-02-07 2000-05-02 Becton, Dickinson And Company Quality control procedure for membrane flow-through diagnostic assay devices
US5885526A (en) 1997-03-25 1999-03-23 Chu; Albert E. Analytical device for membrane-based assays
DE69840657D1 (de) * 1997-07-16 2009-04-23 Charm Sciences Inc Verfahren zum Nachweis eines Restanalyts in einer Probe
AUPP131098A0 (en) 1998-01-13 1998-02-05 Bellon Pty Limited Identification of particles and macromolecular species
US6312888B1 (en) 1998-06-10 2001-11-06 Abbott Laboratories Diagnostic assay for a sample of biological fluid
AU4562599A (en) 1998-06-12 1999-12-30 New Horizons Diagnostics, Inc. Colloidal colorimetric flow through and lateral flow assays utilizing soluble submicron particles
US6287783B1 (en) * 1999-03-18 2001-09-11 Biostar, Inc. Optical assay device and method
US6436722B1 (en) 2000-04-18 2002-08-20 Idexx Laboratories, Inc. Device and method for integrated diagnostics with multiple independent flow paths
WO2002031465A1 (en) 2000-10-13 2002-04-18 Inhalix Pty Ltd Collection of particles to be analysed by assay systems
US6565808B2 (en) 2001-05-18 2003-05-20 Acon Laboratories Line test device and methods of use
US7531362B2 (en) * 2001-06-07 2009-05-12 Medmira Inc. Rapid diagnostic assay
CA2457930C (en) 2001-08-20 2012-06-19 Proteome Systems Intellectual Property Pty Ltd. Diagnostic testing process and apparatus
DE60219207T2 (de) 2001-12-12 2008-01-24 Proteome Systems Intellectual Property Pty. Ltd., North Ryde Diagnostisches testverfahren

Also Published As

Publication number Publication date
EP1419387A1 (de) 2004-05-19
US20050124077A1 (en) 2005-06-09
AU2002331408B2 (en) 2008-05-08
US7205159B2 (en) 2007-04-17
JP2004538488A (ja) 2004-12-24
CA2457930C (en) 2012-06-19
JP4264348B2 (ja) 2009-05-13
CA2457930A1 (en) 2003-02-27
EP1419387A4 (de) 2005-12-14
EP1419387B1 (de) 2012-01-04
US20070190667A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
ATE539816T1 (de) Verfahren zum diagnostischen testen
DE60219207D1 (de) Diagnostisches testverfahren
AU759117B2 (en) Assay using porosity-reduction to inhibit migration
NO20000970L (no) Fremgangsmõte og utstyr for rask analyse av analytter i biologiske stikkprøver
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
DK11186D0 (da) Fremgangsmaade og apparat til immunanalyser
WO2002010754A3 (en) Assay apparatus
WO2005029073A3 (en) Chromatographic assay device and methods
AU2004256206A1 (en) Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test
ATE226729T1 (de) Quantitative immunochromatographische assays
DE60232353D1 (de) Verfahren zum nachweis von analyten durch magnetischen teilchen
PL309211A1 (en) Heterogenous specific bond test used for detection or content determination of a given substance in a sample analysed, method of reducing non-specific bonding in pseudohomogenous tests and testing set for performing immunological test and those employing genetic probe
ATE508365T1 (de) Immunologisch-analytisches verfahren zur bestimmung von glykosylierten proteinen (ages)
GB9709821D0 (en) Allergy assay
ATE548641T1 (de) Verfahren zum verdünnen einer flüssigkeit und zum erkennen von analyten in einer verdünnten flüssigkeit
DE69938701D1 (de) Verfahren und vorrichtung zum nachweis von antikörpern
DE60016779D1 (de) Assay-vorrichtung
AU5559594A (en) Rapid immunologique test for the optical determination of progesterone in fluids
CA2434694A1 (en) Detection and quantification of cripto-1
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
WO2002014869A3 (en) Assay method and device for detecting the presence and concentration of analytes
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
WO2005067486A8 (en) Quantitative protein assay using single affinity capture agent for identification and detection
FR2319903A1 (fr) Procede et appareillage pour effectuer des analyses chimiques et cliniques